You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港醫思醫療集團(02138.HK)完成收購醫學實驗室測試服務公司75%股份
格隆匯 01-06 19:59

格隆匯1月6日丨香港醫思醫療集團(02138.HK)公吿,2020年12月14日,公司、公司間接全資附屬Jade Master International Limited作為買方、Sunny Sea Global Limited作為賣方及賣方擔保人(目標公司董事Leung Yang Shih Ti Marianne)訂立買賣協議,據此,其中包括,賣方有條件同意出售第一批銷售股份(相當於目標公司已發行股本的75%),總代價為3.375億港元,包括應付賣方的現金代價金額2.295億港元;及將配發及發行予賣方的代價股份(值1.08億港元)。

第一批完成後,目標公司將成為公司的附屬公司,且目標公司的財務報表將於集團綜合入賬。於本公吿之日,第一批收購已經完成,而目標公司的財務報表將綜合入賬集團。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account